BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND WT1, WAGR, 7490, ENSG00000184937, WT33, GUD, WIT-2
227 results:

  • 1. Overexpression of wt1 in all molecular subtypes of breast cancer and its impact on survival: exploring oncogenic and tumor suppressor roles of distinct wt1 isoforms.
    Ben Haj Othmen H; Othman H; Khamessi O; Bettaieb I; Gara S; Kharrat M
    Mol Biol Rep; 2024 Apr; 51(1):544. PubMed ID: 38642153
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comprehensive Transcriptomic Analysis of EWSR1::wt1 Targets Identifies CDK4/6 Inhibitors as an Effective Therapy for Desmoplastic Small Round Cell Tumors.
    Magrath JW; Sampath SS; Flinchum DA; Hartono AB; Goldberg IN; Boehling JR; Savkovic SD; Lee SB
    Cancer Res; 2024 May; 84(9):1426-1442. PubMed ID: 38588409
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Oxidative stress enhances rotavirus oncolysis in breast cancer and leukemia, except in melanoma with abundant matrix.
    Guerrero M; Hernández J; Gomez L; Guerrero C
    Virus Res; 2024 Jan; 339():199285. PubMed ID: 38013142
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Frontiers of Ovarian Carcinosarcoma.
    Ismail A; Choi S; Boussios S
    Curr Treat Options Oncol; 2023 Dec; 24(12):1667-1682. PubMed ID: 37938504
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The clinicopathological and immunohistochemical features of breast carcinomas with signet-ring-cell differentiation.
    Zheng J; Liu J; Yang W; Yao J; Guo J; Liu C
    World J Surg Oncol; 2023 Jun; 21(1):181. PubMed ID: 37337182
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Immunohistochemical Characterization of a Large Cohort of Triple Negative breast cancer.
    Han R; Nofech-Mozes S; Boles D; Wu H; Curcin N; Slodkowska E
    Int J Surg Pathol; 2024 Apr; 32(2):239-251. PubMed ID: 37306115
    [No Abstract]    [Full Text] [Related]  

  • 7. Establishment of an experimental model of canine malignant mesothelioma organoid culture using a three-dimensional culture method.
    Sato Y; Elbadawy M; Suzuki K; Tsunedomi R; Nagano H; Ishihara Y; Yamamoto H; Azakami D; Uchide T; Nabeta R; Fukushima R; Abugomaa A; Kaneda M; Yamawaki H; Shinohara Y; Usui T; Sasaki K
    Biomed Pharmacother; 2023 Jun; 162():114651. PubMed ID: 37030135
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Molecular Modes of Action of an Aqueous
    Rashan LJ; Özenver N; Boulos JC; Dawood M; Roos WP; Franke K; Papasotiriou I; Wessjohann LA; Fiebig HH; Efferth T
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838857
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Management of patients with presumed germline pathogenic variant from tumor-only genomic sequencing: A retrospective analysis at a single facility.
    Kawamura M; Shirota H; Niihori T; Komine K; Takahashi M; Takahashi S; Miyauchi E; Niizuma H; Kikuchi A; Tada H; Shimada M; Kawamorita N; Kanamori M; Sugiyama I; Tsubata M; Ichikawa H; Yasuda J; Furukawa T; Aoki Y; Ishioka C
    J Hum Genet; 2023 Jun; 68(6):399-408. PubMed ID: 36804482
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. wt1 as a myoepithelial marker: a comparative study of breast, cutaneous, and salivary gland lesions.
    Ng JKM; Li JJX; Lai BSW; Tsang JY; Chan AWS; Cheung CMT; Ip ECC; Tse GM
    Hum Pathol; 2023 May; 135():76-83. PubMed ID: 36739952
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Metastatic spread of serous ovarian carcinoma to the bilateral breasts: a rare presentation.
    Musa A; Joiner M; Dzul S; Miller SR
    BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36423949
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Changing the landscape of European School of Oncology-European Society for Medical Oncology masterclasses in clinical oncology during the COVID-19 pandemic.
    Pavlidis N; Peccatori FA; Eniu A; Rassy E; Aapro M; Cavalli F; Lordick F; Costa A
    Future Oncol; 2022 Aug; 18(25):2857-2864. PubMed ID: 35722882
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma.
    Lamhamedi-Cherradi SE; Maitituoheti M; Menegaz BA; Krishnan S; Vetter AM; Camacho P; Wu CC; Beird HC; Porter RW; Ingram DR; Ramamoorthy V; Mohiuddin S; McCall D; Truong DD; Cuglievan B; Futreal PA; Velasco AR; Anvar NE; Utama B; Titus M; Lazar AJ; Wang WL; Rodriguez-Aguayo C; Ratan R; Livingston JA; Rai K; MacLeod AR; Daw NC; Hayes-Jordan A; Ludwig JA
    Nat Commun; 2022 Jun; 13(1):3057. PubMed ID: 35650195
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prevalence of (Epi)genetic Predisposing Factors in a 5-Year Unselected National Wilms Tumor Cohort: A Comprehensive Clinical and Genomic Characterization.
    Hol JA; Kuiper RP; van Dijk F; Waanders E; van Peer SE; Koudijs MJ; Bladergroen R; van Reijmersdal SV; Morgado LM; Bliek J; Lombardi MP; Hopman S; Drost J; de Krijger RR; van den Heuvel-Eibrink MM; Jongmans MCJ
    J Clin Oncol; 2022 Jun; 40(17):1892-1902. PubMed ID: 35230882
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. N
    Huang T; Cao L; Feng N; Xu B; Dong Y; Wang M
    Bioengineered; 2021 Dec; 12(2):10935-10944. PubMed ID: 34866525
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Clinicopathological features of verrucous hemangioma].
    Fan PH; Liang D; Jia LJ; Gong YB; Sun B; Fu LL; Liu QY
    Zhonghua Bing Li Xue Za Zhi; 2021 Dec; 50(12):1341-1345. PubMed ID: 34865421
    [No Abstract]    [Full Text] [Related]  

  • 17. Giant benign lymphangioendothelioma with positive expression of Wilms tumor 1: A case report.
    Teixeira D; Canelhas Á; Costa M; Magalhães C; Ferreira EO; César A
    J Cutan Pathol; 2022 Jan; 49(1):86-89. PubMed ID: 34423872
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinicopathological significance of wt1 expression in invasive breast carcinoma with >90% mucinous component.
    Xu X; Bi R; Shui R; Yu B; Cheng Y; Tu X; Yang W
    J Clin Pathol; 2022 Dec; 75(12):832-836. PubMed ID: 34244341
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Proteolysis-Targeting Chimeras Enhance T Cell Bispecific Antibody-Driven T Cell Activation and Effector Function through Increased MHC Class I Antigen Presentation in cancer Cells.
    Massafra V; Tundo S; Dietzig A; Ducret A; Jost C; Klein C; Kontermann RE; Knoetgen H; Steegmaier M; Romagnani A; Nagel YA
    J Immunol; 2021 Jul; 207(2):493-504. PubMed ID: 34215653
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. New mutation in wt1 gene in a boy with an incomplete form of Denys-Drash syndrome: A CARE-compliant case report.
    Akramov NR; Shavaliev RF; Osipova IV
    Medicine (Baltimore); 2021 May; 100(19):e25864. PubMed ID: 34106634
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 12.